| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Bassler Bonnie L is a Director at RPRX, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 26 sales. Those positions are worth an estimated $6.0M at current prices.
Our model assigns Bassler Bonnie L a middling insider score of 59/100, based on 22 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of +4.5%.
Bassler Bonnie L's largest disclosed position is in RPRX as Director, worth about $4.7M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 1,500 | $800.00 | $1,200,000.00 | -46.8% | -6.4% | - | |
| Nov 20, 2025 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 760 | $750.00 | $570,000.00 | -32.9% | +7.5% | - | |
| Aug 15, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 756 | $1,170.00 | $884,520.00 | -35.4% | -31.6% | -50.6% | |
| Aug 2, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 756 | $1,115.00 | $842,940.00 | -35.4% | -22.5% | -48.4% | |
| Jun 24, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 756 | $1,062.00 | $802,872.00 | -35.4% | +2.6% | -50.9% | |
| Jun 5, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 827 | $1,011.00 | $836,097.00 | -37.4% | +16.2% | -52.0% | |
| Feb 26, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 854 | $979.25 | $836,279.50 | -38.2% | -1.6% | -26.9% | |
| Jan 30, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 827 | $959.00 | $793,093.00 | -37.4% | -7.0% | -28.4% | |
| Jan 3, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 826 | $914.00 | $754,964.00 | -37.4% | +4.0% | -22.1% | |
| Dec 13, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 610 | $870.00 | $530,700.00 | -32.8% | +10.8% | -15.4% |